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The  Standards  for  Reporting  of  Diagnostic  Accuracy  (STARD)  statement  (www.stard-
statement.org) was developed  to encourage  complete  and  transparent  reporting  of key
elements  of test  accuracy  studies  in human  medicine.  The  statement  was  motivated  by
widespread  evidence  of  bias  in test  accuracy  studies  and  the  finding  that  incomplete  or
absent reporting  of items  in the  STARD  checklist  was  associated  with  overly  optimistic
estimates  of  test  performance  characteristics.  Although  STARD  principles  apply  broadly,
specific  guidelines  do  not  exist  to account  for unique  considerations  in  livestock  studies
such as herd  tests,  potential  use  of experimental  challenge  studies,  a more  diverse  group  of
testing  purposes  and  sampling  designs,  and  the  widespread  lack of  an  ante-mortem  refer-
ence standard  with  high  sensitivity  and  specificity.  The  objective  of  the  present  study  was
to develop  a  modified  version  of  STARD  relevant  to paratuberculosis  (Johne’s  disease)  in
ruminants.  Examples  and  elaborations  for  each  of  the  25  items  were  developed  by  a  panel
of experts  using  a consensus-based  approach  to explain  the  items  and  underlying  concepts.
The  new  guidelines,  termed  STRADAS-paraTB  (Standards  for Reporting  of  Animal  Diagnos-
tic Accuracy  Studies  for  paratuberculosis),  should  facilitate  improved  quality  of reporting
of the design,  conduct  and  results  of  paratuberculosis  test  accuracy  studies  which  were
identified as  “poor”  in a  review  published  in  2008  in  Veterinary  Microbiology.
© 2011 Elsevier B.V. All rights reserved.
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1. Introduction
The Standards for Reporting of Diagnostic Accuracy
(STARD) statement (www.stard-statement.org) was pub-
lished in 2003 in several leading medical journals with an
overall goal of improving reporting of test accuracy studies
in human medicine (Bossuyt et al., 2003a,b). The statement
includes a checklist of 25 key items and a flow diagram
that accounts for patient losses, including lack of reference
standard testing during the diagnostic work-up. Although
focused primarily on clinical patients in hospitals and refer-
ral clinics, the principles apply equally well to subclinical
diseases regardless of whether they are infectious (Peeling
et al., 2006; TDR Diagnostics Evaluation Expert Panel, 2006)
or non-infectious. Absence or underreporting of STARD
items has been associated with overly optimistic estimates
of test accuracy (Lijmer et al., 1999).
Methodological aspects of studies, including their
design and statistical analysis, are not explicitly mentioned
in STARD and a separate 14-item tool, named QUADAS
(Quality Assessment of Diagnostic Accuracy Studies) is
used for such assessments (Whiting et al., 2003). Different
study designs can be used for the same purpose and appli-
cation of a test. In general, prospective designs likely are
preferable to retrospective studies using repository sam-
ples because of improved data quality and completeness
of information on covariates that influence variability in
test accuracy. However, poor reporting may  occur in both
well-designed and flawed test accuracy studies.
A structured approach to the design of test evaluation
studies for chronic infections in animals has recently been
proposed (Nielsen et al., 2011) but the manuscript does
not address reporting guidelines. In a prior study, one of
us proposed that a modification of STARD checklist items
was necessary to increase applicability to and perhaps
adoption of its use in animal studies (Gardner, 2010). Sug-
gested changes included modification of terminology to be
consistent with the REFLECT (Reporting Guidelines for Ran-
domized Control Trials) statement for trials in livestock and
food safety (O’Connor et al., 2010), inclusion of herd tests
and other testing purposes, potential use of challenge stud-
ies, an expanded concept of clinical utility of findings, and
more variable sampling designs as examples.
Over the last 2 decades, there has been increased inter-
est in developing novel tests or improving existing tests for
detection of paratuberculosis (Johne’s disease), caused by
infection with Mycobacterium avium subsp. paratuberculo-
sis (MAP). An important goal of much of the research has
been to identify tests of greater sensitivity and specificity
that detect infection at an earlier stage, thereby minimiz-
ing production losses. Nielsen and Toft (2008) reviewed
85 test validation studies for paratuberculosis that mostly
involved serum ELISA tests in cattle and identified multiple
design and reporting flaws. Many of the published studies
were considered by the authors to be of poor quality.
This paper describes a consensus-based reporting list of
items, based on a modification of STARD, for field-based
test accuracy studies for individual and herd classifica-
tion of MAP  infection status. The new guidelines are
termed STRADAS-paraTB (Standards for Reporting of Ani-
mal  Diagnostic Accuracy Studies for paratuberculosis). As a
prerequisite for designation of appropriate checklist items,
we assumed that the test under evaluation (TUE) had
been optimized in laboratory experiments and prelimi-
nary estimates of sensitivity, specificity, repeatability and
reproducibility were available using a limited number of
well-characterized samples. In addition, we assumed that
results of the validation to this level, which corresponds
to Stage I in the World Organisation for Animal Health
(OIE) pathway (OIE, 2010), had been published in a peer-
reviewed journal.
2. Methods and processes
The STARD statement was  developed by a 9-person
steering committee and a group of invited experts (Bossuyt
et al., 2003a). A similar approach was  used for the
STRADAS-paraTB initiative. Two preliminary face-to-face
meetings were held in Minnesota in 2008 (4 co-authors)
and 2009 (7 co-authors) to decide if modification of STARD
was necessary to increase relevance to paratuberculosis
test accuracy studies, to define changes if modification was
necessary, and to develop a plan to obtain additional sci-
entific input prior to publication.
As a sequel to these initial efforts, a meeting was held
in Orlando in March 2010 with a goal of finalizing the
checklist and identifying examples and elaborations. The
final list and manuscript was  compiled by 12 partici-
pants (9 from USA and 1 each from Australia, Denmark
and the Netherlands) who attended at least one of the
meetings. The expertise of the contributors was  broadly
classified as basic scientist/researcher, epidemiologist, and
clinician/diagnostician and several participants were asso-
ciate editors or editorial board members of journals. Nine of
12 participants had authored or co-authored a manuscript
on paratuberculosis test accuracy and 8 had authored a
paper that was evaluated by Nielsen and Toft (2008).  At
the Orlando meeting, consensus about changes in the orig-
inal STARD items was  deemed to have occurred when at
least 80% of participants voted for a suggested change or
for no change in the wording of the item. A final oppor-
tunity to review and approve the wording changes was
made approximately one month prior to submission of this
manuscript for publication and during manuscript revision.
3. Examples, explanations and elaborations
Of the original 25 STARD checklist items, we  modified
18 (2– 6, 8–11, 13, 15–18, and 22–25) to reflect input
of the experts (Table 1). Relevant examples and expla-
nations for each item were based on expert input where
each co-author contributed based on their experience and
knowledge of published studies. In the examples, we  use
square brackets when the original text was  changed to
improve clarity e.g. spelling out of acronyms and insertion
of additional words. For 3 items (14, 17 and 20), we  only
provide an explanation because the STARD example is suf-
ficient (Bossuyt et al., 2003b).  Definitions and terms used
in the manuscript are in Appendix 1.
Item:1 Identify the article as a study of diagnostic accu-
racy (recommend MeSH heading of “sensitivity and
specificity”).
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Table 1
Checklist of items for reporting of diagnostic test accuracy studies for paratuberculosis in ruminants based on the STARD checklist (www.stard-
statement.org).
Section and topic Item Description of item On page
Title/abstract/keywords 1 Identify the article as a study of diagnostic accuracy (recommend MeSH heading ‘sensitivity and
specificity’).
Introduction 2 State the research question or study aims such as estimation of diagnostic accuracy or comparison of
accuracy between tests in a specified matrix (specimen type) for a defined purpose at the animal or
herd level
Materials and Methods
Animals and herds 3 Describe study sampling frame: Describe the source population and inclusion and exclusion criteria,
setting and locations where data were collected for all relevant levels of the study sample (animals and
herds)
4 Describe selection of animals and herds: Describe sample selection methods (random, convenience,
etc.) within each level of the sampling hierarchy (e.g. regions, farms, barns, cows) including exclusion
criteria and number of study animals and herds.
5  Describe sampling protocol: Describe the collection, specimen size, transportation, handling and
storage of specimens prior to the performance of the test under evaluation (TUE) and the reference
standard.
6  Describe study design: Was  data collection planned before the TUE and reference standard were
performed (prospective study) or after (retrospective study)?
Test  methods 7 Describe the reference standard and its rationale.
8 Describe technical specifications of materials and methods involved including how and when
measurements were taken, and/or cite references for TUE and reference standards. Specify quality
control samples for TUE and reference standard and specimen/analytical unit size of tested samples.
9  Describe the outcome measure and rationale for the cutoffs and/or categories of the results of the TUE
and  reference standard.
10 Describe the name, location, and qualifications of the laboratory, including the number, training and
expertise of persons executing the TUE and reference standard.
11 Describe whether or not the readers of the TUE and reference standard were blind (masked) to the
results of the other test and describe any individual or herd-level information available to the readers.
Statistical methods 12 Describe methods for calculating or comparing measures of diagnostic accuracy, and the statistical
methods used to quantify uncertainty (e.g. 95% confidence intervals).
13  Describe methods for calculating test repeatability and reproducibility, if done.
Results
Animals and herds 14 Report when study was done, including beginning and end dates of recruitment
15 Report demographic and other biologically relevant characteristics of the study sample at the
individual (e.g. age, sex, breed, and risk factors) and at the herd levels (e.g. production system).
16  Report the number of animals and herds satisfying the criteria for inclusion that did or did not undergo
the  TUE and/or the reference standard: describe why animals and herds failed to receive either test.
Test  results 17 Report time interval between collection of samples for the TUE and the reference standard, and
interventions administered between.
18 Report distribution of severity of disease or stage of infection (define criteria), and other relevant
diagnoses or treatments in animals in the study sample.
19 Report a cross tabulation of the results of the TUE (including indeterminate and missing results) by the
results of the reference standard; for continuous results, the distribution of the test results by the results
of  the reference standard.
20 Report any adverse events from performing the TUE or the reference standard.
Estimates 21 Report estimates of diagnostic accuracy and measures of statistical uncertainty (e.g. 95% confidence
intervals).
22  Report how indeterminate results, missing responses and outlier values of the TUE and the reference
standard were handled. If additional testing of animals and herds is done to resolve discrepant results,
then  describe the rationale and approach (a flow diagram is strongly recommended).
23 Report estimates of variability of diagnostic accuracy between relevant subpopulations, readers, or
testing sites, if done.
24  Report estimates of test repeatability and reproducibility, if done.
Discussion 25 Discuss the utility of the TUE in various settings (clinical, research, surveillance etc.) in the context of
the currently available tests.
Modifications of text from the STARD checklist are in italics and bold. TUE (test under evaluation) is used instead of index test as used in STARD.
Example (Objective statement from a structured
abstract)
To estimate the sensitivity (Se) and specificity (Sp) for an
enhanced direct-fecal PCR procedure, bacterial culture of
feces (BCF), and a serum ELISA for detecting Mycobacterium
avium subsp. paratuberculosis (MAP) infection in adult dairy
cattle (Scott et al., 2007).
Explanation
Electronic retrieval of relevant manuscripts is a
key component of primary diagnostic test accuracy
research and is necessary for systematic litera-
ture reviews. The Medical Subject Headings (MeSH:
www.ncbi.nlm.nih.gov/mesh) includes the terms paratu-
berculosis, Johne’s disease and Mycobacterium avium
subsp. paratuberculosis and lists 4 possible headings or
subheadings relevant to diagnostic test evaluation: (1)
sensitivity and specificity; (2) predictive value of tests; (3)
ROC curves; and (4) limit of detection. The term “diag-
nostic accuracy” is not a MeSH term. Hence, the terms
“sensitivity and specificity” should be included in at least
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one of the 3 designated locations (title/abstract/keywords)
as is done in the structured abstract in the example. The
terms “herd”, “flock” or “aggregate” are not listed in MeSH.
PubMed searches for “herd OR sensitivity” yield similar
numbers of manuscripts to those obtained when the only
search term is “sensitivity”.
Item:2 State the research question or study aims such as
estimation of diagnostic accuracy or comparison of
accuracy between tests in a specified matrix (spec-
imen type) for a defined purpose at the animal or
herd level.
Example
The aim of this study was to develop and evaluate a
method for culturing of fecal samples pooled from a num-
ber of sheep in order to provide an economical test for M.
avium subsp. paratuberculosis in flocks. Specific aims were
to determine an acceptable rate of pooling of fecal sam-
ples, to compare the sensitivities of pooled fecal culture
and an AGID [agar gel immunodiffusion] test, to evaluate
the practicality of sample collection, and to develop recom-
mendations for sampling rates for confirmation of M. avium
subsp. paratuberculosis infection in flocks (Whittington et
al., 2000).
Explanation
A clearly defined research objective relative to the TUE
enables the reader to determine the validity of the test
evaluation study in the context of the purpose of test-
ing. The OIE endorses the concept of “fitness for purpose”
in validation of diagnostic tests and lists 6 purposes: (1)
to demonstrate population ‘freedom’ from infection (zero
prevalence); (2) to demonstrate freedom from infection
or agent in individual animals or products for trade pur-
poses; (3) to eradicate infection; (4) to confirm a diagnosis
of clinical cases; (5) to estimate prevalence of infection to
facilitate risk analysis; and 6) to determine immune status
in individual animals or populations (OIE, 2010). In the con-
text of paratuberculosis, additional purposes, e.g. to control
MAP to maximize profit, are relevant. Examples of MAP-
specific testing purposes are given in Collins et al. (2006)
and Nielsen and Toft (2008).  The purpose for testing (i.e.
proposed use or application of the test) should be explic-
itly stated to assist readers in making inferences about
application of results. Generally, test accuracy estimates
are considered to be valid only for the purpose for which the
test has been validated and purpose-specific test validation
in one population cannot be generalized unconditionally to
other populations without careful scrutiny prior to accep-
tance (Greiner and Gardner, 2000). The example above
would be improved by specification of geographic location
in the abstract or objective, although this information can
be ascertained by further examination of the publication.
Item:3 Describe study sampling frame: Describe the
source population and inclusion and exclusion
criteria, setting and locations where data were col-
lected for all relevant levels of the study sample
(animals and herds).
Example (Hypothetical based on revision of information
in Lombard et al., 2006)
The target and source populations for the National Ani-
mal  Health Monitoring System’s Dairy 2002 study were
operations and cows in 21 states that represented at least
70% of the dairy cows and dairy operations in the US. The
median size of dairy herds in these states was 110 cows
(range, 60–1800). A cow was  defined as an adult bovid that
had given birth to at least one calf. The study sample for
Phase II was  a stratified random sample of operations in
the 21 states and was restricted to operations with at least
30 cows and where the operator was willing to participate
in biologic sample collection.
Explanation
For paratuberculosis test accuracy studies, information
about the target population may  only be available for a lim-
ited number of descriptors, mostly at the herd level (e.g.
species and for cattle, whether dairy or beef (non-dairy),
herd size, and geographic location such as region or state)
and is unlikely to be readily available for paratuberculosis
testing history etc. Paratuberculosis prevalence and dis-
tribution in the target and source populations should be
reported, if known. The relevant information for the herds
can be presented as means (medians) and standard devi-
ations (ranges) for quantitative variables, and frequencies
for categorical variables. The example represents a mod-
ification of a prior report (Lombard et al., 2006) to more
clearly define the target and source populations. Another
example (see item 4) is Pitt et al. (2002) which reports
the number of dairy herds in a geographically defined
target population. Location of the target and source popu-
lations is important since this factor may  affect specificity
of antibody tests for paratuberculosis. Detailed descrip-
tive information relevant to the study sample is easier to
obtain compared with the target and source populations
and should be reported for biologically important variables
described in item 15.
Item:4 Describe selection of animals and herds: Describe
sample selection methods (random, convenience,
etc.) within each level of the sampling hierarchy
(e.g. regions, farms, barns, cows) including exclu-
sion criteria and number of study animals and
herds.
Example
The dairy cattle industry in north Queensland is con-
fined to three shires on the Atherton Tablelands and has
202 herds in total. Herds included in the study were
those assessed as being most at risk of having JD [Johne’s
disease]. This assessment was  done in consultation with
advisers and private veterinarians and by review of herd
health records, past JD ELISA and complement fixation test-
ing, interstate import records and local knowledge. Risk
factors included cases of chronic diarrhea, wasting, unex-
plained deaths and introductions from states with endemic
JD. Twenty-five dairy herds were identified as at risk by
this initial assessment and, of these, 18 were sampled
in the preliminary round of testing that was  conducted
between August and November 1995. A total of 475 dairy
cows.....were included in the study. At least 25 mature cows
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Target population
Source population
Study sample
Selection level 
(herds/animals)
Inclusion/exclusion criteria
Herds: sold or dispersed
Animals: died, sold, culled, missing 
data on test results
Herds: unknown MAP status; herd 
size restriction; owners unwilling to 
participate
Animals: age/lactation number, 
disease stage
Losses to follow-up: reasons
Fig. 1. Generic flowchart for reporting of relevant information for the
source population and study sample in a diagnostic test evaluation study
for paratuberculosis in ruminants.
per herd were sampled, and cows that had a positive or
high negative result in the absorbed ELISA were subject
to further investigation..... which included three collections
of feces for bacteriological culture and blood sampling for
absorbed ELISA..... Retesting [fecal culture and ELISA test-
ing for 19 cows] was performed in late November 1995, in
March 1996 and in June 1996 (Pitt et al., 2002).
Explanation
Two-stage sampling (herds selected first and then ani-
mals within herds) is often used for test evaluation studies
for paratuberculosis. If the term “random” is used to
describe herd and animal selection, a formal description of
the procedure should be used. An example that includes
description of a stratified random sampling protocol is
Scott et al. (2007).  Although the STARD statement uses the
term “participant” in several items, “participant” should
be reserved for the owner or manager of the herd and its
animals and who gives permission to collect samples for
testing (O’Connor et al., 2010). Herd owners (participants)
are recruited but it is the animals or herds to which the
tests are applied. There may  be instances where herd own-
ers are asked, but decline, to participate which could bias
a study, e.g. registered breeders afraid of a negative impact
on their reputation/sales if positive test results are found.
Accounting for inclusion and exclusion of herds and
animals can be done in the text or in a simple flowchart
(Fig. 1). To our knowledge, flowcharts have not been used
for reporting of paratuberculosis test accuracy studies but
could enhance reader understanding of complex sampling
protocols. Fig. 2 shows the herd and animal selection pro-
cess for a study that evaluated a milk ELISA for MAP
(Lombard et al., 2006) and was constructed by the lead
author of that paper for purposes of this report. The study
was conducted as part of a large-scale national study which
makes the flowchart more complicated than the majority of
test accuracy studies. Criteria for inclusion at the 2 critical
steps (National Agricultural Statistics Service (NASS) sam-
ple and selection for MAP  testing) are shown. Although the
study started with a random sample of dairy operations,
the operations that participated in the evaluation were a
convenience sample. Selection of cows for testing was  also
not random. The study sample selected for serum ELISA and
fecal culture testing was cows that were primarily second
lactation or greater and cows for milk testing were only
lactating cows.
Item:5 Describe sampling protocol: Describe the collec-
tion, specimen size, transportation, handling and
storage of specimens prior to the performance of
the TUE and the reference standard.
Example
There were five groups of samples for this study
(Table 1). The first two  were pooled fecal samples used in an
earlier study. The remaining three were pooled fecal sam-
ples, individual fecal samples and tissue samples submitted
by veterinarians during routine surveillance for ovine
paratuberculosis or collected during field-based epidemio-
logical studies or experimental infections.....Fecal samples
were submitted chilled (approximately 4 ◦C),sometimes
via other laboratories. Upon receipt at the main labora-
tory, samples were placed at 4 ◦C or at −80 ◦C if they
could not be processed within 4 days. Some samples were
homogenised upon receipt then stored at −80 ◦C if cul-
ture was  to be delayed.....The interval between collection
of samples from sheep on the farm and receipt of those
samples at the laboratory ranged from 1 to 7 days (median
3 days). Processing capacity was sometimes exceeded at
the laboratory, necessitating storage of samples at −80 ◦C
upon receipt. Consequently there were variable receipt-
to-homogenisation (range 0–54 days, median 1 day) and
homogenisation-to-decontamination (range 0–29 days,
median 1 day) intervals (Whittington, 2009).
Explanation
Sample handling procedures may  affect test accuracy
estimates. Specific information on sample collection vol-
ume, use of individual sleeves for collection of feces,
shipping information such as delays, on ice, etc. should also
be included in the Materials and Methods section of the
manuscript, wherever applicable. An example where there
is complete description of sample collection and handling
for serum, tissues and feces is McKenna et al. (2005a). For
pooled samples, the weights of fecal material or number
of pellets should be specified as well as the sample sizes
and additional handling procedures, if relevant. Scott et al.
(2007) provides a good example of the necessary informa-
tion for pooled sampling.
Item:6 Describe study design. Was  data collection planned
before the TUE and reference standard were
performed (prospective study) or after (retrospec-
tively)?
Example
Three hundred and seventy-one animals.....were
included in the present study and retrospectively cate-
gorized as follows: (1) infected animals that produced at
least one culture-positive fecal sample in the study period
(n = 42 animals), or were culture-positive from tissue sam-
ples at slaughter (n = 2, only a limited number of animals
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Fig. 2. Flowchart for herd and animal selection based on the National Animal Health Monitoring System’s Dairy 2002 study (Lombard et al., 2006). The
chart  was  prepared by one of the coauthors (JL) based on the original manuscript and other reports and data. DHIA = Dairy Herd Improvement Association;
VMO  = Veterinary Medical Officer; NASS = National Agricultural Statistics Service.
were tissue cultured); (2) exposed animals (n = 208), orig-
inated from infected herds, but without culture-positive
fecal samples in the sampling period; (3) non-infected
animals (n = 119), originating from five non-infected herds
that were without evidence of paratuberculosis at the
time of herd selection.....and without any culture-positive
samples in the following 2-year study period (Huda et al.,
2004).
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Explanation
Retrospective designs use the results of the reference
standard and TUE from samples collected in the past. For
example, the performance of various strategies to classify
herd-level MAP  infection status (herd-level TUEs) could be
evaluated using test results of individual cattle from herds
previously tested (Jordan, 1996). In prospective designs,
samples are collected and the TUE and reference stan-
dard are evaluated after the initiation of the study and,
presumably, for the purpose of test evaluation. Results of
retrospective studies may  be valid, but because the test
samples often were collected for a different purpose, it is
possible for selection bias to affect the estimates of test
performance. Prospective studies have the advantage of
forethought in subject and sample selection. The sequence
of testing is important when the study animals are selected.
The required sample size often is reduced if some selection
criteria, including historical information about the study
units, are included based on retrospective sampling. How-
ever, these selection criteria, which could favor selection
of animals with advanced stages of infection, can poten-
tially lead to spectrum bias and overestimation of test
performance, unless the data are interpreted within the
selection strata (Ransohoff and Feinstein, 1978; Nielsen
et al., 2011). Therefore, prospective sampling including a
completely random inclusion of animals would generally
be more appropriate but make the required sample size
larger. Hence, it is important to specify the sequence of data
collection and the study design (Nielsen et al., 2011) so the
reader can appropriately judge the inferences.
Item:7 Describe the reference standard and its rationale.
Example
The advantage to the use of tissue culture as a com-
parison standard represents a wider spectrum of animals
representing all stages of disease for determination of sen-
sitivity.....It is apparent that the use of tissue culture as a
gold standard results in a lower estimate of [ELISA] sen-
sitivity.....The specificity estimates determined here were
included for completeness; however, a more accurate com-
parison standard for specificity estimation would be ani-
mals from herds known from their history not to be infected
with Mptb [MAP]. This type of information was not avail-
able for the cattle used in this study. Therefore, the speci-
ficity estimates determined here would be more appro-
priately viewed as apparent specificity based on a non-
conventional comparison standard (McKenna et al., 2005a).
Explanation
Choice of and justification for the reference standard is a
critical issue in test evaluation studies. In the McKenna et al.
(2005a) study, two different reference standards (tissue
culture results and fecal culture results) were used based on
samples collected at slaughter. Each is described in detail in
the text, including sample collection, preparation, storage
conditions, and culture methodology and isolate confir-
mation. The authors report the sensitivity and specificity
and 95% confidence intervals (CI) of 3 ELISAs relative to
the two described reference standards. The discussion sec-
tion of the cited manuscript includes considerations of the
relative merits of each positive reference standard and dis-
cussion of the negative reference standard in this study
(tissue culture- or fecal culture-negative) versus a more
stringent standard. The reference standard at the herd-
level may  involve multiple criteria and risk-based sampling
may  be used to establish the true herd status.
Item:8 Describe technical specifications of materials and
methods involved including how and when mea-
surements were taken, and/or cite references for
TUE and reference standards. Specify quality con-
trol samples for TUE and reference standard and
specimen/analytical unit size of tested samples.
Example
Two types of controls were used for the fecal PCR
assay. Extraction controls were tested once per extrac-
tion. For negative extraction controls, DNA was  extracted
from fecal samples from cattle from dairy herds known
to be uninfected (level 4 of the Voluntary Johne’s Dis-
ease Test Negative Program for Cattle) and tested with
the MAV2 TaqMan PCR assay. Positive extraction con-
trols were created by extracting DNA from fecal samples
from cattle known to be uninfected that was  then spiked
with M. avium subsp. paratuberculosis and tested with the
MAV2 TaqMan PCR assay. In the MAV2 TaqMan PCR assay,
positive template controls consisted of dilutions of M.
avium subsp. paratuberculosis DNA (previously extracted),
with two positive template controls per plate. Eight no-
template controls (NTC) consisting of nuclease-free water
were tested per test plate (Wells et al., 2006).
Explanation
Complete description of culture methods is needed
because laboratories often modify methods to suit their
needs including availability of media and reagents, and
there are substantial differences in sensitivity and contam-
ination associated with these methodological variations
(Whittington, 2010). Unambiguous definitions of positive
and negative test results are required. In contrast to serum
ELISA testing where use of quality control samples plate on
each 96-well plate is standard practice in most laborato-
ries, control samples (e.g. feces from a low MAP  shedder)
are typically not used by most laboratories evaluating
culture-based methods. A description of quality control
(QC) samples used in a fecal PCR evaluation study (Wells
et al., 2006) is used as the example for this item to show
the needed information.
Item:9 Results of the TUE and reference standard.
Example
The ELISA A reports the analyzed optical densities (OD)
as an S/P ratio (sample OD to positive control OD ratio).
The ELISA B reports as a score value, which is determined
in relation to the cut-off that is determined by the mean
of the negative controls plus 0.100. The ELISA C reports a
pp-value (percent positive), which is based on a regression
analysis of log–log transformed OD values. The calculation
involves generating a linear regression of the blanked OD
values and “log–log” transformed OD values, and using the
inverse slope of this line multiplied by the log of the OD
of the sample to arrive at the pp-value. This calculation
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is performed to standardize the linear relationship of the
test values with corresponding increases in antibody levels
(McKenna et al., 2005b).
Explanation
To improve comparability of test results from different
runs of the same ELISA assay or results from different lab-
oratories, the data often are standardized (or normalized)
based on values of positive and negative quality control
samples which are included on each plate. The example
from McKenna et al. (2005b) provides a description of cal-
culations and reporting of data transformations involved
with ELISA. The criteria for interpretation of normalized
data must be prescribed; for example, a positive result for
a paratuberculosis ELISA was defined as a S/P ratio >70% in
Gumber et al. (2006).  When herd status for MAP  is deter-
mined based on ELISA test results of multiple individual
samples, there are 2 cutoff values – the cutoff (threshold)
for interpretation of each individual test results and the
number (or percentage) of positive test results – to desig-
nate the herd-level TUE result as positive (Christensen and
Gardner, 2000). Regardless of whether an indirect detec-
tion test (IDT) or a direct detection test (DDT) is evaluated,
the number of individual samples tested by the TUE and ref-
erence standard for herd classification should be reported.
Real-time PCR data may  be normalized by various
means but the number of targeted genomic copies derived
from a standard curve of Ct (cycle threshold) values is con-
sidered to be the most appropriate method (Bustin et al.,
2009). The standard curve is based on a series of internal
controls, and it provides within-assay assessment of the
limit of detection in that particular run. Lower limits of
detection usually are not well defined and are stochasti-
cally limited (Bustin et al., 2009), which is a problem for
selection of a positive–negative cutoff value. Technically
the detection limit should lie within the range of Ct of the
standard curve.
Item:10 Describe the name, location, and qualifications of
the laboratory, including the number, training and
expertise of persons executing the TUE and refer-
ence standard.
Example
Each of the technicians involved [in 2 laboratories that
participated in an evaluation of interlaboratory variation in
test results of a commercial ELISA kit] had passed a national
proficiency test for the ELISA method of detecting antibod-
ies to MAP  in bovine serum (Adaska et al., 2002).
Explanation
The number, training, and expertise of those carrying
out the TUE should be reported, not only in order to allow
evaluation of the investigators’ expertise, but also to facil-
itate comparisons between studies using the same TUE
and to make possible inferences with regard to potentially
discordant results. The diagnostic accuracy of a particu-
lar TUE or reference test may  be affected by variability in
the manipulation, processing or reading of the test results
by the individual(s) conducting the assays and interpret-
ing their results (Elmore and Feinstein, 1992). Information
about the training and expertise of these individuals can
provide a reader with an idea of data quality. The more
extensive the expertise and training of the individual(s)
conducting the test, the more confidence the reader can
have in the interpretation of the assay (Brealey et al., 2002).
Appropriate examples for paratuberculosis are rare with
the exception of the example shown (Adaska et al., 2002).
Item:11 Describe whether or not the readers of the TUE
and reference standard were blind (masked) to
the results of the other test and describe any indi-
vidual or herd-level information available to the
readers.
Example
Laboratory personnel were blinded to the common
identity of the milk and fecal samples (Hendrick et al.,
2005).
Explanation
Information about blinding of personnel performing the
TUE and the reference standard test is essential so readers
can assess potential bias in the study. Knowledge of the
results of the reference standard can influence the inter-
pretation of the TUE, and vice versa. Such knowledge is
likely to increase the agreement between results of the
TUE and those of the reference standard, leading to bias,
and possibly an inflated measure of diagnostic accuracy
(Philbrick et al., 1980). Withholding information from the
individual(s) conducting the test, including results of other
tests, is critical to minimize or prevent bias. Studies have
shown that inappropriate masking may  have substantial
effects and produce an inaccurate measure of test accuracy
(Detrano et al., 1989; Lijmer et al., 1999). If a blinded third
party broke code after the analysis was  done, this should
also be mentioned. Blinding might be difficult to achieve
for small research teams but is highly desirable and should
be the recommended standard of practice. Strategies that
can assist blinding include bar-coding of samples and use
of an outside source or personnel specifically dedicated to
that task.
Item:12 Describe methods for calculating and comparing
measures of diagnostic accuracy and statistical
methods used to quantify uncertainty in the esti-
mates (e.g. 95% confidence intervals).
Example 1 (Hypothetical based on modification of
Collins et al. (2005)
The sensitivity and specificity of the 5 ELISA tests were
estimated with 95% confidence intervals (CI) accounting
for the clustered sampling of animals in 7 infected and
7 non-infected herds, respectively (Dohoo et al., 2009).
McNemar’s test for correlated proportions was  used to
evaluate whether pairs of tests had different sensitiv-
ities and specificities at p = 0.05. Likelihood ratios (LR)
for serum-to-positive intervals of assay A results were
computed with 95% confidence intervals (CI) using the
Med-Calc software (www.medcalc.be/). In Medcalc, CI for
LR are estimated using a Poisson approximation with no
adjustment for clustering.
Example 2
We  applied latent-class models.....in a Bayesian frame-
work to estimate the Se and Sp of the ELISA and the
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FC....., separately in sheep and in goats. The estimation of
Se and Sp of the ELISA and the FC was based on their
cross-classified results. For the method to be valid, three
main assumptions need to be met: (a) the diagnostic tests
should be conditionally independent of each other.....; (b)
the target population should consist of two or more sub-
populations with different prevalence (P); (c) in these
sub-populations, the Se and Sp of the diagnostic tests
should be constant (Kostoulas et al., 2006).
Explanation
A unique aspect of test evaluation studies in animal
compared with human medicine is use of clustered designs
which typically require accounting for the design effect
and inflation of variance estimates when CI are estimated
(Dargatz and Hill, 1996; Dohoo et al., 2009). In a longi-
tudinal design, repeated testing using the TUE will yield
correlated results that need to be accounted for in the case
definition for positive/negative results or in the statisti-
cal analysis. To our knowledge, adjustment for clustering
has not been used for paratuberculosis studies but could
be reported as shown in example 1. For CI calculation,
the method used should be specified. Normal approxima-
tions are unlikely to be appropriate for small samples and
when estimates are close to zero or unity. Exact meth-
ods, which are increasingly used, are preferable to normal
approximations but provide conservative interval esti-
mates (Newcombe, 1998).
Because latent-class statistical methods are used fre-
quently in paratuberculosis test accuracy studies for
samples collected ante-mortem (see for example, Nielsen
et al., 2002 and Wells et al., 2006), the methods and under-
lying assumptions inherent in the approach should be
described as in the second example. For Bayesian analyses,
the prior distributions should be specified and justified. For
more complex models with covariates (Norton et al., 2010),
the modeling section of the paper should provide greater
detail and code for Bayesian models should be included in
an appendix or referenced.
Item:13 Describe methods for calculating test repeatabil-
ity and reproducibility, if done.
Example
Variance components were calculated for the S/P [sam-
ple OD to positive control OD] ratios. Four factors were
considered as sources of variability in the S/P ratios: labora-
tory, kit lot, wells of the 96-well microtiter plate in which a
particular sample was tested, and date of testing. The date
factor represents day-to-day variability. The contribution
of each of the factors to the overall variability in S/P ratios
was estimated [using Proc Varcomp program in SAS]. Ratios
for the P and HP samples were analyzed separately. All fac-
tors were assumed to be random, and the well in a plate
was nested within kit lot (Dargatz et al., 2004).
Explanation
Repeatability of a test at the sample level and at the
laboratory analytical level and analytical or procedural
reproducibility, defined as between laboratory variation,
are important considerations for assessing how well a test
might perform when used within the same laboratory over
time and among laboratories, respectively. Most studies
of repeatability and reproducibility for paratuberculosis
involve ELISA tests (see for example Collins et al., 1993;
Dargatz et al., 2004; Gumber et al., 2006). Data analy-
sis typically involves estimation of the standard deviation
(SD) or the CV of replicate samples among plates and
laboratories for ultimate use as a quality assurance cri-
terion. The CV is most appropriately used when the SD
is proportional to the mean of the replicates. Sometimes,
more complex designs with variance components models
are used to quantify the relative contributions of differ-
ent sources of variation (Dargatz et al., 2004) as shown in
the example. Repeatability and reproducibility for dichoto-
mous or ordinal test results can be estimated using kappa
values which measure the chance-corrected agreement
within and between laboratories, respectively (Dohoo et al.,
2009). If repeatability of the TUE has been estimated and
reported in a prior study, the relevant citation should be
given.
Evaluations of the repeatability and reproducibility of
DDT, especially culture and PCR, are rare; an exception is
Kawaji et al. (2007).  Lack of sample homogeneity may  be a
very influential factor affecting the reproducibility of a DDT,
especially in samples transported to other laboratories.
Although repeatability and reproducibility of DDT can be
evaluated using spiked samples, use of naturally contam-
inated fecal samples from low to moderate MAP  shedders
would likely better represent the combined effects of han-
dling, storage, and transportation in addition to potential
clumping of MAP  which might be impossible to replicate
in a spiking experiment.
Item:14 Report when study was done, including beginning
and end dates of recruitment.
Explanation
For most published paratuberculosis studies, the begin-
ning and end dates of the study are included with
information about sampling protocol in the Materials and
Methods section as shown in the item 4. However in longi-
tudinal studies, reporting of details of recruitment may  be
necessary. Huda et al. (2004), for example, indicated that
animals entered their study at 12 months of age.
Item:15 Report demographic and other biologically rele-
vant characteristics of the study sample at the
individual (e.g. age, sex, breed, and risk factors)
and at the herd levels (e.g. production system).
Example
Dairy cattle from 14 herds were included in the study.
All herds were comprised of Holstein cattle, except one
that had Jerseys. The uninfected population was  com-
prised of 359 adult cattle from seven Minnesota dairy
herds designated status level 4 according to the criteria
of the U.S. Voluntary Bovine Johne’s Disease Herd Status
Program.....Seven known M. paratuberculosis-infected Wis-
consin herds, comprised of 2094 adult cattle, were used
to find cases of bovine paratuberculosis. These herds had
no previous history of systematically testing for paratu-
berculosis or removal of test-positive cattle. The infected
and non-infected herds were similar in many respects,
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including their standardized risk assessment scores for M.
paratuberculosis infection transmission (Table 1) (Collins
et al., 2005).
Explanation
MAP  infections are chronic with several infection stages.
The age distribution and distribution of animals in different
infection stages can greatly affect the sensitivity estimates
and should be reported separately by subpopulation (item
18), wherever possible. Furthermore, the reader should be
able to understand the production system in which the
animals were kept so that the applicability to other pop-
ulations can be assessed. Prior testing history and actions
taken on the basis of test results can affect generalizabil-
ity of results and should be described as in the example.
Risk assessment scores also provide a useful summary
assessment of implemented herd management practices
to control paratuberculosis. When data from a few herds
(<20) are included in the study, relevant information may
be represented in tabular format as done in the example
and in Gumber et al. (2006),  or it may  be summarized as
percentages as in Hope et al. (2000).
For the study sample, the following animal and herd
information was considered essential by the experts for
inclusion under this item. Other information may  be rel-
evant depending on the specific circumstances:
Animal: clinical status (clinical vs. subclinical); age or
lactation number; stage of lactation at testing for dairy cat-
tle.
Herd: geographic location (country and region/state),
herd size with the criterion e.g. animals greater than 2
years (for herd-level diagnostics at least); whether paratu-
berculosis vaccination used (yes/no and if yes, brand name
and manufacturer of vaccine used, and date of last vaccina-
tion); and production and/or housing system (e.g. freestall,
drylot, tiestalls, stanchion barn, pasture etc.). This was  con-
sidered to be essential for herd-level tests but only useful
for individual tests. Skin testing history for Mycobacterium
bovis may  impact antibody test results for paratuberculosis
(Varges et al., 2009) and should be reported. Prior paratu-
berculosis testing history is an important consideration
since selective removal of test-positive animals, whether
true or false-positive, can substantially impact sensitivity
and specificity estimates (Whitlock et al., 2000). An exam-
ple of reporting of within-herd test prevalence for study
herds is provided in Aly et al. (2010).
Item:16 Report the number of animals and herds satisfy-
ing the criteria for inclusion that did or did not
undergo the TUE and/or the reference standard:
describe why animals and herds failed to receive
either test.
Example
Of the 35 [dairy] operations, 21 had individual animal
fecal culture results. Three of the 21 operations had no
cattle that tested fecal culture positive, and so were not
included in the fecal culture analysis.....Milk and serum
ELISA results were available for 8552 and 6874 animals,
respectively..... A total of 6349 animals had [both] milk and
serum ELISA results, and of these, 1921 animals had fecal
culture results (Lombard et al., 2006).
Explanation
In cross-sectional designs where testing by the TUE and
reference standard do not occur simultaneously and in lon-
gitudinal studies, there can be multiple reasons why  some
cows and/or herds do not undergo all testing. For example,
in the study by Lombard et al. (2006),  cows that were not
lactating at the time of the milk ELISA could not have been
tested. Since all testing was not conducted simultaneously,
some animals may  have been removed or died in the period
between tests. Additionally according to study protocols,
first lactation animals were to be excluded from serum
ELISA and fecal culture testing. Also, the number of herds
with fecal cultures done was lower than for ELISA testing
because of laboratory capacity issues. These discrepancies
in numbers tested by each of the assays evaluated could
be shown in a table (see item 19 for a modified example
using the data from Lombard et al., 2006), in a flowchart or
in a simple case, described in the text. An example where
death loss and reason for death are reported is Pitt et al.
(2002).
Item:17 Report time interval between collection of sam-
ples for the TUE and the reference standard, and
interventions administered between.
Explanation
For practical purposes, some sample types, e.g. milk,
often are collected on different days from blood and feces
collections because milk sampling is regularly scheduled
by dairy industry associations in some countries. In addi-
tion, it is well known that fecal culture and ELISA results
for paratuberculosis fluctuate over time and therefore
investigators sometimes use a composite reference stan-
dard based on longitudinal test results. In these cases,
the time (mean or median and range) between sequen-
tial tests of the same test type should be reported in
either the results or methods section. A further problem
arises when necropsy data are used as the reference stan-
dard and the TUE was  based on samples collected earlier
in life rather than at the time of necropsy when disease
would be expected to have progressed to more advanced
stages. Although there are few published data, sequen-
tial biopsy results from the terminal ileum and associated
lymph nodes of naturally exposed sheep have shown that
histopathological status can remain unchanged or change
from negative to positive (most animals), positive to neg-
ative (few animals), or paucibacillary to multibacillary
within 6 months (Dennis et al., 2011).
Treatments for paratuberculosis are not used in com-
mercial operations but there is evidence that use of
monensin sodium in dairy rations reduces ELISA positiv-
ity and fecal shedding of MAP  (Hendrick et al., 2006a,b)
and hence, its use should be reported. Other interventions
(paratuberculosis vaccination or skin testing for tuberculo-
sis) might affect IDT results (see items 18 and 20).
Item:18 Report distribution of severity of disease or stage
of infection (define criteria), and other relevant
diagnoses or treatments in animals in the study
sample.
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Example
The distribution of shedding rates among the culture-
positive cows shows a preponderance of cows (45%) in
the very low shedding category (Fig. 1).....There was  a
direct relationship between the level of fecal shedding of
M. paratuberculosis and the percentage of positive assays
(table 3). [For the 415 culture-positive cattle, the num-
bers of cattle were 229, 68, 36, and 82 in shedding level
categories of >0–1, >1–2, >2–3, and >3–4, respectively].
Positive ELISAs were found for 6.9–28.6% (mean, 13.3%) of
cows with low numbers of M.  paratuberculosis in their feces
(fecal scores > 0–1). At progressively higher fecal culture
scores, the mean percentages of positive antibody assays
for all five assays were 27.3, 54.9, and 78.4%, respectively
(Collins et al., 2005).
Explanation
Spectrum bias affects sensitivity (Ransohoff and
Feinstein, 1978). For chronic infections such as paratu-
berculosis, the timetable of infection progression makes
disease spectrum readily evident (Nielsen et al., 2011).
Generally, diagnostic tests perform better in late-stage
paratuberculosis when the number of organisms in feces
and tissues is high or when antibody concentration in
serum and milk is high. Conversely, early in the course
of infection, these same analytes are low in number or
even absent making sensitivity poor. Thus, papers eval-
uating paratuberculosis diagnostic tests should explicitly
describe the spectrum of disease in the study sample. Ide-
ally, the spectrum of infection stages (proportion of animals
in each infection stage) in the study sample should reflect
the spectrum of infection stages in the target population.
For paratuberculosis, a common surrogate for infection
severity is the number of MAP  in fecal samples, as used in
Collins et al. (2005).  A better indicator of disease severity
is the histopathogical score at necropsy as reported for 152
infected sheep in Gumber et al. (2006) and for 224 sheep
used for evaluation of ELISA in Sergeant et al. (2003).
Item:19 Report a cross tabulation of the results of each TUE
(including indeterminate and missing results) by
the results of the reference standard; for continu-
ous results, the distribution of the test results by
the results of the reference standard.
Example
Distribution of milk and serum ELISA results and MAP
culture results by fecal shedding level (table 5) from Lom-
bard et al. (2006).
Explanation
Lack of clarity in presentation of the joint results of mul-
tiple diagnostic tests is common in many test evaluations
for paratuberculosis. An exception is Alinovi et al. (2009)
where results of 4 tests were cross-tabulated. Table 5 in
Fecal culture
shedding
Milk ELISA Serum ELISA Milk and serum ELISA
Total Strong positive (%) Positive (%) Negative (%) Strong positive (%) Positive (%) Negative (%) Positives (%)
Heavy 13 61.5 15.4 23.1 53.8 38.5 7.7 69.3
Moderate 26 38.5 15.4 46.1 38.5 11.5 50.0 46.1
Low  83 7.2 3.6 89.2 4.8 4.8 90.4 6.0
Very  low 48 2.1 4.2 93.7 4.2 10.4 85.4 4.2
Negative 1751 0.3 1.2 98.5 0.2 1.6 98.2 0.3
Total 1921 1.6 1.7 96.7 1.4 2.3 96.3 1.8
Lombard et al. (2006),  as shown in the example, presents
a cross classification of serum ELISA and milk ELISA results
individually and jointly by level of fecal culture shedding,
as evaluated by parallel interpretation of results from 3 cul-
ture methods (n = 1921). However, discordant test results
(milk positive and serum negative, and vice versa) were
not explicitly reported. Greater transparency would have
been achieved had results of all 3 tests been reported for
all 6097 cattle that were tested by any of the 3 methods.
The modified table (shown below) for dichotomized fecal
culture results was  reconstructed from the original data.
This table also serves to completely account for milk and
serum ELISA when no fecal sample was  cultured (Not tested
(NT) = 4176). A similar table could have been generated for
the 105 herds, if considered warranted.
Milk ELISA Serum ELISA Fecal culture Total
+ + + 28
+  + − 6
+  − + 8
+  − − 21
− + + 12
− − + 122
− + − 26
− − − 1698
+ + NT 93
+  − NT 56
− + NT 106
− − NT 3921
A novel way  of presenting detailed test results across
multiple populations was  recently published (Caraguel et
al., 2009). The same approach might have utility in paratu-
berculosis test accuracy studies.
Item:20 Report any adverse events from performing the
TUE or the reference standard.
Explanation
Only in rare circumstances, would the TUE or reference
standard have adverse consequences. If the reference stan-
dard is an invasive procedure such as full thickness ileum
biopsy, there is the risk of standard post-surgical compli-
cations, and the presence or absence of these should be
reported with the diagnostic test evaluation or separately
(McConnel et al., 2004). Other situations where there might
be unintended consequences include instances where skin
test antigens could result in allergic reactions in the tested
subject or alter immune responses to subsequent tests as
was  demonstrated with M. bovis (Buddle et al., 2010).
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Item:21 Report estimates of diagnostic accuracy and a
measure of statistical uncertainty (e.g. 95% con-
fidence intervals).
Example 1 (Hypothetical example based on modifica-
tion of Collins et al., 2005)
The sensitivities of the ELISA to detect cows shedding
MAP  in feces did not differ for 4 of the ELISAs (P > 0.05) and
ranged from 28.0% to 28.9% but all these assays were lower
than the sensitivity for assay D (44.5%, P < 0.05). Overall
specificity among the 5 ELISAs evaluated ranged from 84.7%
for assay D to 100% for assay C. Assay D had significantly
(P < 0.05) lower specificity than all other assays, and assay
A had significantly lower specificity than B, C and E. Sensi-
tivity and specificity estimates and clustered-adjusted 95%
confidence intervals (CI) for each assay are in table X. For
assay A, the LR (95% CI) for the 3 categories of test results
above the manufacturer recommended cutoff of 0.25 were
1.5 (95% CI = 0.8–3.0), 11.3 (95% CI = 2.7–47.1) and 63.2 (95%
CI = 8.8–452.1) for serum-to-positive ratios in the intervals
of >0.25–0.4, >0.4–1.0, and >1.0, respectively.
Example 2
Of the 400 animals initially sampled, results on both
FC [fecal culture] and ELISA for 368 were obtained. For
each species, cross-classified results of the ELISA and FC by
sub-population are in table 3. At the recommended ELISA
cutoff (S/P value = 0.4), posterior medians obtained under
the independence model for the SeELISA, SpELISA, SeFC and
SpFC, were 63% (95% CrIs [credibility intervals]: 42, 93%),
95% (90, 98%), 8% (2, 17%) and 98% (95, 100%) in goats and
37% (10, 80%), 97% (93, 99%), 16% (2, 48%) and 97% (95, 99%)
in sheep, respectively (Kostoulas et al., 2006).
Explanation
Regardless of the choice of measure of diagnostic
accuracy (sensitivity, specificity, likelihood ratios, area
under the ROC curve), test performance results should
be reported with 95% CI (or probability intervals in a
Bayesian analysis) to capture the uncertainty in param-
eter estimates. The ease with which this can been done
has increased with on-line calculators, freeware software
programs, and the incorporation of estimators in commer-
cial packages (e.g. SAS, Stata, Medcalc) and freeware (e.g.
R, WinBUGS). The two examples demonstrate concise yet
complete reporting of salient information based on the sta-
tistical methods described in item 12. The approaches for
herd-level sensitivity and specificity estimation are similar
to those for animal-level estimation and CI should be cal-
culated based on the number of infected and non-infected
herds that were tested, respectively.
Item:22 Report how indeterminate results, missing
responses and outlier values of the TUE and the
reference standard were handled. If additional
testing of animals and herds is done to resolve
discrepant results, then describe the ratio-
nale and approach (a flow diagram is strongly
recommended).
Example
All DNA templates extracted from fecal samples were
tested by the QPCR assay in duplicate, and in the case of
contradiction (1 of 2 wells positive) the fecal sample was
retested from the beginning of the DNA extraction. If either
well was positive in the second test, the sample was defined
as positive.(Kawaji et al., 2007).
Explanation
The example based on PCR testing provides a straight-
forward description of the necessary information. For
culture, contamination with organisms other than MAP
may  be an issue irrespective of whether solid or liq-
uid media are used. A retrospective analysis of test
performance by Whittington (2009),  in which irrelevant
microorganisms were observed on 16% of the primary cul-
tures on 7H10+MJ agar from the 1535 samples and in 76%
of the 551 subcultures from BACTEC medium, provides an
adequate description of the needed information. If addi-
tional testing or retesting is used to ultimately classify
initial results that are indeterminate or outliers, the criteria
for selection of samples should be described. An example
of plate and sample-level quality control criteria for deter-
mining the need for ELISA retesting is Gumber et al. (2006).
There are different implications of applying additional
testing depending on whether it is done on the reference
test or the TUE. For example, adding a confirmatory test to
the reference standard will increase specificity but reduce
the sensitivity of the reference standard. This reduced pool
of “true disease positives” will likely generate a higher esti-
mate of sensitivity for the TUE. Adding a confirmatory test
to the TUE will reduce its sensitivity and increase its speci-
ficity.
Item:23 Report estimates of variability of diagnostic accu-
racy between relevant subpopulations, readers, or
testing sites, if done.
Example
The overall sensitivity of ELISA was  34.9% (95% con-
fidence limits, 27.3–43.0) from 152 infected sheep but
it varied from 19.3% to 50.0% depending on the extent
of histopathological lesions [table 3 includes details].
The sensitivity of ELISA was  greater for animals hav-
ing histopathological lesion types HS 2 and HS 3 than
for animals with other lesion categories. The sensitiv-
ity on the basis of positivity of both tissue culture and
histopathology results was  32.8%.....The sensitivity of ELISA
increased uniformly as the duration of exposure of animals
increased.....(table 5).....The specificity of ELISA for sheep
from Western Australia and NSW was 99.4% and 98.3%,
respectively. The overall specificity of ELISA irrespective of
states was 98.8% (table 6) (Gumber et al., 2006).
Explanation
Examples where subpopulations have influenced
reported test accuracy values for paratuberculosis are
common and predominantly involve bias in prevalence or
stage of disease in the study animals. Although there is no
formal relationship between prevalence and sensitivity in
epidemiological theory, in practice paratuberculosis test
sensitivity is affected by prevalence as it drives the contact
rate with infected animals and the level of environmental
contamination. The MAP  load in the environment affects
the degree of exposure and hence the incubation period,
and therefore the proportion of individuals at a given
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age which have reached a stage of disease consistent
with fecal shedding or immunological response (reviewed
in Whittington and Sergeant, 2001). For this scenario,
apparent sensitivity of both fecal tests and serum ELISA
for testing of any age stratum is improved.
Histological examination of intestine and associated
lymph nodes provides one way of classifying/standardizing
animals by stage of disease, as does body condition score,
so that inferences can then be made to other herds based
on expected proportions of cases at each disease stage.
Although few reports would meet all criteria of reporting
subpopulation detail, examples with adequate geographic
origin, age and stage of disease data for ELISA, AGID or
fecal culture/PCR are Gumber et al. (2006) and Kawaji
et al. (2007).  Examples where prevalence and stage of
disease data have been reported with test accuracy esti-
mates include Sergeant et al. (2002, 2003).  Infections by, or
exposures to, microbes that share antigens with MAP  may
cause variability in estimates of specificity. For paratuber-
culosis in goats, concomitant infection or vaccination with
Corynebacterium pseudotuberculosis impacted the diagnos-
tic specificity of one ELISA kit for paratuberculosis more
than another (Manning et al., 2007). Geographic location
may  impact specificity of ELISA in cattle (Pitt et al., 2002),
presumably due to exposure to environmental mycobac-
teria. Effects of covariates on sensitivity and specificity can
be assessed by stratification or logistic regression modeling
(Coughlin et al., 1992).
Herd-level sensitivity of a TUE is likely to be strongly
dependent on within-herd prevalence of MAP  and report-
ing of estimates by prevalence should be done. An example
where the performance of a commercial ELISA used on
bulk-tank milk samples was related to within-herd ELISA
seroprevalence is Van Weering et al. (2007).
Item:24 Report estimates of test repeatability and repro-
ducibility, if done.
Example
Modeling the S/P ratio for the P sample showed that the
largest amount of variation was attributed to the kit lot
(37.5%), followed by random error (27.0%) and interlabora-
tory variation (18.3%) (table 4). Modeling the S/P ratio for
the HP sample showed a somewhat different distribution
for the sources of variation (table 5). The largest proportion
of the variation was attributed to random (unexplained)
error (55.0%) followed by date (21.4%) and laboratory
(17.1%). To assess the impact of plates with a low degree
of separation between the negative and positive control
means, 2 additional analyses were conducted for the S/P
ratios for the P samples (table 6). In the first analysis, 19
plates in which the separation was less than 0.3 were not
included and the percent contribution of the factors to the
variance reassessed. This analysis was repeated once more,
not including all plates with a separation of less than 0.4
(136 observations) (Dargatz et al., 2004).
Explanation
There is at least one study of repeatability at the sam-
ple level to evaluate how a single fecal sample represents
feces from the cow at that time (Eamens et al., 2007). For
detection of antigen or nucleic acid from MAP  cells in low
abundance, stochastic events associated with taking a sub-
sample from a larger fecal sample may  affect repeatability
and should be reported as the frequency of occurrence of
discrepant results among duplicates, the method of reso-
lution of discrepancies, and the definition of positive and
negative test outcomes where retests are required; an
example is provided by Kawaji et al. (2007).  In addition, it
is well known that histopathological examination becomes
more sensitive as more levels or sections of intestine or
lymph node are examined because a single sample may
not be representative of the tissue as a whole.
Analytical or procedural reproducibility among labora-
tories can be reported as SD or as the relative contribution
from different sources of S/P ratio variability as in the exam-
ple by Dargatz et al. (2004).
Item:25 Discuss the utility of the TUE in various settings
(clinical, research, surveillance etc.) in the context
of the currently available tests.
Example
Selection of an assay (e.g., among serum ELISA, BCF
[bacterial culture of feces], and PCR assay) is not straight-
forward and will depend on such factors as cost; laboratory
capacity, performance, and efficiency; and diagnostic test
accuracy. Despite apparent relative improvements in Se
and Sp for the qRT-PCR assay over values for the serum
ELISA and Se for the qRT-PCR assay over that for BCF, other
factors may  be important when considering the appropri-
ate test for a given herd situation and diagnostic laboratory.
For example, although the enhanced direct-fecal qRT-PCR
assay performed best for the commercial herd described
here, other herds that contain many more young and pre-
clinical (e.g., non-shedders or low shedders) cattle or cattle
of unknown infection status may  not be suitable for testing
with this assay. A large herd with unknown MAP  infec-
tion status would be more suited to screening by use of
the serum ELISA, with follow-up confirmation of positive
results by use of BCF, rather than to initiate testing with
a relatively expensive alternative such as the direct qRT-
PCR assay. On the other hand, in a herd of known infection
status that contains older cows and in which culling deci-
sions need to be made in a timely manner, the direct-fecal
qRT-PCR assay may play a more important role (Scott et al.,
2007).
Explanation
The concept of utility of a diagnostic test, as demon-
strated in the example, has much broader implications
in veterinary medicine, and especially livestock health, as
compared to human medicine. Tests must be affordable
for end-users in addition to having high accuracy. One way
of addressing this is to incorporate economic outcomes
into methods for setting the optimal assay cutoff for a
specified purpose. Alternatively, conventional methods
of assay accuracy, e.g. ROC analysis, can be used to estab-
lish assay sensitivity and specificity, which then can be
incorporated into more sophisticated economic decision
analysis models (Dorshorst et al., 2006). Regardless, of the
method employed, a thorough diagnostic assay evaluation
should include discussion of assay utility. Producers should
expect that the benefits of use of the assay for a designated
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purpose will outweigh the costs of testing. Laboratories
should expect that the assay can be performed with
sufficient throughput to meet client expectations, and at a
laboratory fee that clients consider affordable. The paper
should discuss, with regards to these indicators, how the
current TUE compares to other commercially available
tests in common use.
4. Conclusions and recommendations
STRADAS-paraTB is an expert-derived list of items based
on STARD for improving the quality of reporting of test
accuracy studies for paratuberculosis. Use of the checklist
can potentially benefit many end-users of paratuberculosis
tests including livestock owners, veterinarians, and animal
health officials for the purpose of developing and imple-
menting surveillance and testing programs for control
of paratuberculosis. Moreover, the checklist and guide-
lines can assist researchers developing tests, reviewers and
journal editors who subsequently consider manuscripts
reporting research results for publication. We  recommend
that authors complete the STRADAS-paraTB checklist and
include with their submitted manuscript. Journals publish-
ing paratuberculosis test accuracy studies should “strongly
encourage” the use of the checklist at all stages of the
review process and could publish the list as a supple-
mental file. Because STRADAS-paraTB focuses on reporting
standards and not design, we recommend that authors of
paratuberculosis test accuracy studies consult Nielsen et al.
(2011) for guidance about design aspects and strategies to
prevent common biases evident in many published paratu-
berculosis validation studies.
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Appendix A. Terms and definitions
Paratuberculosis (Johne’s disease): The MeSH defini-
tion is “a chronic gastroenteritis in ruminants caused by
Mycobacterium avium subsp. paratuberculosis”. However,
the definition is restrictive and should include any subclin-
ical stage of paratuberculosis infection.
Mycobacterium avium subsp. paratuberculosis (MAP): A
subspecies of Gram-positive, aerobic bacteria of the genus
Mycobacterium. It is the etiologic agent of paratuberculo-
sis (Johne’s disease), a chronic gastroenteritis in ruminants
(MeSH definition). Additional genomic considerations are
described in Turenne et al. (2007).
Target condition: Underlying MAP  infection status of
interest (e.g. infected, infectious, or affected states of indi-
vidual animals or herds). The target condition is normally
measured based on quantification of an analyte or bio-
logical marker (e.g. MAP  organisms or serum antibodies
to MAP) that the test under evaluation (TUE) or reference
standard detects as an indicator of the target condition.
Affected: A MAP-infected animal exhibiting one or more
clinical signs of disease, such as weight loss, diarrhea, or
edema.
Subclinical infection: A MAP-infected animal that
appears clinically normal, i.e. does not have overt dis-
ease signs (observable by the herd owner or veterinarian)
compatible with paratuberculosis such as diarrhea and
low body condition, or reduced milk production. Most
MAP-infected cows in a MAP-infected herd will be in the
subclinical stage of infection.
Infected (non-infected) animal:  An animal that has (does
not have) MAP  in its tissues.
Infected (non-infected) herd: A herd that has at least one
MAP-infected animal (zero MAP-infected animals).
Infectious (non-infectious) animal:  An animal that
excretes (does not excrete) sufficient MAP  bacteria to
potentially infect one or more non-infected animals. Infec-
tious animals are a sub-population of all MAP-infected
animals.
Case definition: A practical definition of the target con-
dition typically defined by the results of the reference
standard.
Reference standard: A highly accurate diagnostic test, or
combination of tests or observations that is used to clas-
sify the status of animals or herds according to the target
condition. The term “gold standard” applies to a reference
standard that is 100% sensitive and specific, or virtually so.
Often, the term leads to unrealistic expectations and its
use as an absolute standard precludes demonstration that
a TUE has superior accuracy (Wilks, 2001). Ante-mortem
“gold standards” do not exist for paratuberculosis.
Test under evaluation (TUE): A diagnostic method pro-
posed for use to classify animals or herds with regard to
the target condition. In STARD, the TUE is referred to as
the “index test”.
Test types
Direct detection tests (DDT):  Tests that detect the live
MAP  organism or any subcomponent unique to MAP  such
as a gene by PCR, or antigen by immunoassay. DDT yield
binary (positive/negative) or semi-quantitative results. The
latter includes measurements such as the number of
colony-forming units (CFU) per gram of cultured speci-
men  on solid media, days-to-positive in liquid media or
the number of cycle threshold (Ct) values for quantitative
real-time PCR assays.
Indirect detection tests (IDT): Tests that quantify immune
response such as antibodies to MAP  in matrices such as
serum or milk. IDT typically provide semi-quantitative
results such as optical densities (OD) or sample-to-positive
(S/P) ratios. These results are often interpreted as positive
or negative at a single cutoff (threshold) value or using
multiple cutoffs (e.g. low and high), as recommended by a
test-kit manufacturer or diagnostic laboratory.
Test parameters
Animal-level sensitivity:  The probability that an animal
with the target condition (e.g. MAP  infection) will test pos-
itive with the TUE.
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Herd-level sensitivity:  The probability that a herd with
at least one animal with the target condition (e.g. MAP
infection) will test positive with the TUE.
Animal-level specificity:  The probability that an animal
without the target condition (e.g. MAP  infection) will test
negative with the TUE.
Herd-level specificity:  The probability that a herd with
zero animals with the target condition (e.g. MAP  infection)
will test negative with the TUE.
Repeatability: A measure of the variability of test results
in a single laboratory usually conducted by the same per-
son (e.g. within run, run-to-run, or day-to-day). For tests
measured on a continuous scale, repeatability is often
expressed as standard deviations (SD) or coefficients of
variation, if the SD is proportional to the mean of the repli-
cates. For categorical tests, kappa is used for binary results
(positive/negative) or in a weighted form when there are
more than 2 categories (e.g. positive, intermediate, and
negative).
Reproducibility: A measure of the variability of test
results among laboratories following the same test
protocol and estimated as for repeatability. Generally,
among laboratory variation (reproducibility) in test results
will exceed within laboratory variation (repeatability).
Both repeatability and reproducibility (at least for direct
tests) will vary enormously depending on the number of
colony-forming units (CFU) in the fecal sample and/or how
uniform or clustered MAP  organisms (or the target) are in
the sample.
Populations, samples and sampling
Populations and study sample:  The target population is
the population to which the estimates of test accuracy
might be extrapolated. The source population is the pop-
ulation from which the study sample is drawn. The study
sample (sometimes termed study population)  is the sam-
ple of animals or herds which are included in the study
(Dohoo et al., 2009).
Convenience sample:  A sample from the source popula-
tion not based on random selection methods.
Herd-level sample: Any type and number of samples
used to classify the MAP  status of a herd (a geographi-
cally defined population (cluster) of animals). Samples can
be collected from individual animals and tested individu-
ally or in pools. In this case, herd-level test interpretation
requires designation of the number or percentage of pos-
itive test results (threshold or cutoff value) required to
classify the herd as MAP-infected. Alternatively, a herd-
level test may  utilize a single herd-level sample (e.g.
bulk-tank milk).
Pooled sample: A composite sample (pool) that is
obtained from at least 2 animals. The investigator controls
the pooling procedure e.g. the number of animals that con-
tribute samples to the pool and the amount or volume of
the specimen.
Random sample: A set of animals drawn from a popu-
lation (e.g. herd) using a formal random selection process
such that each time an animal is selected, every animal in
the population has a known, non-zero probability of inclu-
sion in the sample.
Risk-based sample:  An approach in which the sampled
population is classified into subpopulations (e.g. by age or
lactation number) with different prevalences or risks of
MAP  infection. The population with highest prevalence or
risk of MAP  infection is targeted for sampling to detect MAP,
if present.
Sample size: The number of herds and animals from
which samples were collected for testing.
Specimen size: The volume, weight or dimensions of a
sample matrix submitted for testing by the TUE and/or ref-
erence standard. The amount of material tested (analytic
unit size) in the assay, e.g. PCR, may  be much smaller than
the amount of specimen material submitted.
Prevalence
Within-herd test prevalence:  The apparent (test) preva-
lence of the target condition (e.g. MAP  infection) in a herd,
typically calculated as the number of test-positive results
by the TUE out of the total number of animals tested.
Within-herd true prevalence:  The estimated true preva-
lence of the target condition (e.g. MAP  infection) in a herd.
This value is obtained by correcting the within-herd test
prevalence estimate for the sensitivity and specificity of
the TUE.
Test result classification
Positive: Test result indicative of MAP  infection (e.g. test
signal for an IDT above a defined cutoff value).
Negative: Test result not indicative of MAP  infection (e.g.
test signal for an IDT below a defined cutoff value).
Intermediate: Non-positive, non-negative result (also
termed inconclusive, borderline, suspicious, or suspect in
some test evaluation studies). This classification is based on
construction of a three-zone partition of test results using
two  cutoff values. The cutoffs define three categories of test
results (positive, intermediate, and negative).
Indeterminate: Test result that is not acceptable for tech-
nical reasons. Examples include insufficient response in
positive control wells in gamma  interferon assays, anti-
complementary activity in a serum complement fixation
test, and overgrowth of MAP  cultures with contaminants
precluding counting or observation of CFU.
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